Zenas BioPharma Statistics Share Statistics Zenas BioPharma has 42.11M
shares outstanding. The number of shares has increased by 0.76%
in one year.
Shares Outstanding 42.11M Shares Change (YoY) 0.76% Shares Change (QoQ) 0.66% Owned by Institutions (%) 81.34% Shares Floating 10.31M Failed to Deliver (FTD) Shares 7,838 FTD / Avg. Volume 3.78%
Short Selling Information The latest short interest is 5.55M, so 13.18% of the outstanding
shares have been sold short.
Short Interest 5.55M Short % of Shares Out 13.18% Short % of Float 19.35% Short Ratio (days to cover) 17.89
Valuation Ratios The PE ratio is -2.18 and the forward
PE ratio is -4.84.
Zenas BioPharma's PEG ratio is
-0.01.
PE Ratio -2.18 Forward PE -4.84 PS Ratio 68.44 Forward PS 53.8 PB Ratio 1.1 P/FCF Ratio -2.86 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Zenas BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.21,
with a Debt / Equity ratio of 0.
Current Ratio 6.21 Quick Ratio 6.21 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $38.46K Profits Per Employee $-1.21M Employee Count 130 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax 429K Effective Tax Rate -0.27%
Stock Price Statistics The stock price has increased by 15.68% in the
last 52 weeks. The beta is -1.68, so Zenas BioPharma's
price volatility has been lower than the market average.
Beta -1.68 52-Week Price Change 15.68% 50-Day Moving Average 17.96 200-Day Moving Average 11.42 Relative Strength Index (RSI) 59.56 Average Volume (20 Days) 207,550
Income Statement In the last 12 months, Zenas BioPharma had revenue of 5M
and earned -156.99M
in profits. Earnings per share was -3.76.
Revenue 5M Gross Profit 5M Operating Income -163.89M Net Income -156.99M EBITDA -163.75M EBIT -163.89M Earnings Per Share (EPS) -3.76
Full Income Statement Balance Sheet The company has 319.74M in cash and 1M in
debt, giving a net cash position of 318.74M.
Cash & Cash Equivalents 319.74M Total Debt 1M Net Cash 318.74M Retained Earnings -387.39M Total Assets 293.08M Working Capital 225.36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -119.67M
and capital expenditures -131K, giving a free cash flow of -119.81M.
Operating Cash Flow -119.67M Capital Expenditures -131K Free Cash Flow -119.81M FCF Per Share -2.87
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -3277.76% and -3139.76%.
Gross Margin 100% Operating Margin -3277.76% Pretax Margin -3131.18% Profit Margin -3139.76% EBITDA Margin -3275.02% EBIT Margin -3277.76% FCF Margin -2396.1%
